Activity of axitinib in progressive advanced solitary fibrous tumour: Results from an exploratory, investigator-driven phase 2 clinical study

导出原文传递

翻译打印收藏纠错

作者： Stacchiotti, S. ^[1] ; Simeone, N. ^[2] ; Lo Vullo, S. ^[3] ; Morosi, C. ^[4] ; Greco, F. G. ^[5] ; Gronchi, A. ^[6] ; Barisella, M. ^[7] ; Collini, P. ; Zaffaroni, N. ; Dagrada, G. P. ; Frezza, A. M. ; Mariani, L. ; Casali, P. G.

作者单位： Fdn IRCCS Ist Nazl Tumori, Diagnost Pathol & Lab Med Dept, Milan, Italy ^[1] Fdn IRCCS Ist Nazl Tumori, Mol Pharmacol Unit, Dept Expt Oncol & Mol Med, Milan, Italy ^[2] Fdn IRCCS Ist Nazl Tumori, Sarcoma Unit, Dept Surg, Milan, Italy ^[3] Fdn IRCCS Ist Nazl Tumori, Dept Radiol, Milan, Italy ^[4] Fdn IRCCS Ist Nazl Tumori, Med Oncol Unit 2, Dept Med Oncol, Milan, Italy ^[5] Fdn IRCCS Ist Nazl Tumori, Unit Clin Epidemiol & Trial Org, Milan, Italy ^[6] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy ^[7]

关键词 Sarcoma Solitary fibrous tumour Hemangiopericytoma Target therapy Antiangiogenic Axitinib

发布时间 2019-06-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交